Trusted by
Why Small Biotechs Struggle
Small biotechs can’t afford delays—trial success depends on fast patient enrollment.
-
86% of trials are delayed due to slow patient recruitment.
-
Every month of delay costs millions, delaying regulatory approvals.
-
Without fast recruitment, securing the next funding round becomes uncertain.
How Curewiki Helps Small Biotechs
Curewiki ensures predictable patient enrollment, so you focus on your science, not recruitment struggles.
Continuous patient inflow
No more waiting, patients are delivered where you need them.
Multi-channel recruitment
Capturing willingness to participate from diverse patient & volunteer sources.
AI-driven matching & pre-screening
Reducing site workload & optimizing patient retention.
Just 30 minutes after registering, I received my first call from a potential patient. Curewiki delivers real results!
Maria
Study Coordinator
About Curewiki.
For small biotechs, every recruitment delay threatens funding, regulatory milestones, and market entry. Curewiki ensures predictable patient enrollment by delivering a continuous inflow of engaged patients, so trials stay on schedule and secure the next milestone.
With multi-channel patient acquisition, AI-driven pre-screening, and site-ready patient delivery, we help small biotechs reduce delays, cut recruitment costs, and accelerate clinical development.
Founded in 2022, Curewiki is a European startup with a 17-member team across Europe and funded by public and private sources.
Jean-Sebastien Gosuin
A childhood cancer survivor, Jean-Sebastien founded Curewiki with a mission for everyone to receive effective treatments. He is the CEO of the company.
Edwin Klumper
Ex medico che si trovava spesso a dover affrontare le problematiche di individuare sperimentazioni cliniche per pazienti e conoscenti, Edwin ha fondato un’azienda di ricerca medica prima di entrare a far parte di Curewiki. È responsabile delle relazioni commerciali.
Mieke Fassart
Con 15 anni di esperienza nel settore delle fintech, delle tecnologie sanitarie e del commercio al dettaglio, Mieke guida strategie che collegano i pazienti alle sperimentazioni cliniche con innovazione e impatto misurabile.
Olga Törringer
Con oltre 10 anni di esperienza nel settore tecnologico e digitale, Olga promuove l’espansione del mercato e instaura partnership significative per favorire la crescita.
